Skip Navigation

ECTMIH Day 3: Substandard and falsified medicines

The ACT Consortium drug quality programme shared findings on antimalarial sampling and analysis in a session dedicated to the surveillance of poor quality medicines.

Malaria research publications

Browse through more than 80 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

News from our Partners

At a global meeting in New Delhi, WHO released a new document which describes strategies aimed at controlling and eliminating Plasmodiumvivax, the cause of an estimated 16 million malaria cases worldwide in 2013.

Videos and more

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.